This study tests whether kidneys from donors with hepatitis C can be safely transplanted into people without the virus. Recipients will take the antiviral drug Epclusa for 12 weeks to prevent or treat infection. The goal is to see if this approach is safe and effective, potential…
Phase: PHASE2 • Sponsor: Amit D Tevar, MD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC